<code id='4B64401D41'></code><style id='4B64401D41'></style>
    • <acronym id='4B64401D41'></acronym>
      <center id='4B64401D41'><center id='4B64401D41'><tfoot id='4B64401D41'></tfoot></center><abbr id='4B64401D41'><dir id='4B64401D41'><tfoot id='4B64401D41'></tfoot><noframes id='4B64401D41'>

    • <optgroup id='4B64401D41'><strike id='4B64401D41'><sup id='4B64401D41'></sup></strike><code id='4B64401D41'></code></optgroup>
        1. <b id='4B64401D41'><label id='4B64401D41'><select id='4B64401D41'><dt id='4B64401D41'><span id='4B64401D41'></span></dt></select></label></b><u id='4B64401D41'></u>
          <i id='4B64401D41'><strike id='4B64401D41'><tt id='4B64401D41'><pre id='4B64401D41'></pre></tt></strike></i>

          fashion

          fashion

          author:focus    Page View:3
          U.S. Sen. Bernie Sanders (I-VT) speaks to the media outside of the White House on July 17, 2023 in Washington, DC – politics coverage from STAT
          Sen. Bernie Sanders (I-Vt.) added three drug shortage measures to a pandemic-preparedness bill that his committee will consider Thursday. Kevin Dietsch/Getty Images

          WASHINGTON — Senate health committee Chair Bernie Sanders (I-Vt.) added three drug shortage measures to a pandemic-preparedness bill that his committee will consider Thursday. Only one of them, however, would grant the Food and Drug Administration new authorities to tackle the issue.

          Congress is under pressure to stem drug shortages amid reports of doctors rationing chemotherapies and other essential medicines.

          advertisement

          The new measure would require drug companies to tell the FDA the volume of ingredients they buy from each of their suppliers. Current law requires companies to disclose from whom they buy ingredients, but they don’t need to share how much of the ingredients they source from suppliers.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Report cites 'urgent' need to recruit more diverse clinical trial participants
          Report cites 'urgent' need to recruit more diverse clinical trial participants

          AdobeThepersistentlackofdiversityamongparticipantsinclinicaltrialsisacriticalissuethatisharmingbothp

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          How to bring more disabled researchers into academia

          AdobeDespitebeingthelargestminorityinthenation,disabledpeoplelikeushavebeenstructurallyandinstitutio